Biomarkers are early predictors of various disorders, circulating level of C-reactive protein is a sensitive biomarker of systemic inflammation and may also be associated with the development of diabetic, hepatic, and cardiovascular diseases. In the present study, we aimed to investigate the association between circulating levels of high sensitive C-reactive protein (hs-CRP) and various biomarkers for hepatic, diabetic, and cardiovascular health. The retrospective analysis included 438 individuals who were tested for these panels simultaneously at Vibrant America Clinical Laboratory. The study population included free-living individuals without any preexisting clinical conditions. Among the cardiovascular markers, a positive correlation and significant association was found between high levels of hs-CRP and serum levels of triglycerides (r = 0.0964, p < 0.0428). Quantitative analysis also exhibited a negative correlation of HDL (r = − 0.1423, p < 0.0027) and Apo A (r = − 0.1216, p < 0.0105) with circulating levels of hs-CRP. Among all the diabetic markers, glucose (r = 0.1547, p < 0.0011) and glycated serum protein (r = 0.1725, p < 0.0003) were positively correlated with circulating hs-CRP. In the hepatic panel, AST, a transaminase that plays a vital role in amino acid metabolism, was found to have a strong positive correlation with hs-CRP (r = 0.2139, p < 0.0001). In conclusion, the results clearly show the association of hs-CRP with diabetic, hepatic, and cardiovascular risk factors indicating its central value as a key marker for several lifestyle-associated disorders.
Mugabo, Y., Li, L. and Renier, G. (2010) The Connection between C-Reactive Protein (CRP) and Diabetic Vasculopathy. Focus on Preclinical Findings. Current Diabetes Reviews, 6, 27-34. https://doi.org/10.2174/157339910790442628
Cade, W.T. (2008) Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. Physical Therapy, 88, 1322-1335. https://doi.org/10.2522/ptj.20080008
Lagrand, W.K., Visser, C.A., Hermens, W.T., Niessen, H.W.M., Verheugt, F.W.A., Wolbink, G.J. and Hack, C.E. (1999) C-Reactive Protein as a Cardiovascular Risk Factor: More than an Epiphenomenon? Circulation, 100, 96-102. https://doi.org/10.1161/01.CIR.100.1.96
Park, J.S. and Kim, S.B. (2003) C-Reactive Protein as a Cardiovascular Risk Factor and Its Therapeutic Implications in End-Stage Renal Disease Patients. Nephrology, 8, S40-S44. https://doi.org/10.1046/j.1440-1797.8.s.8.x
Krishnamurthy, H.K., Reddy, S., Jayaraman, V., Krishna, K., Rajasekaran, K.E., Wang, T.H., Bei, K. and Rajasekaran, J.J. (2023) Association of Micronutrients and Prevalence of Antibodies in Hyperthyroidism. In: Gelen, V., Kükürt, A. and Şengül, E., Eds., Hyperthyroidism-Recent Updates, IntechOpen, London. https://doi.org/10.5772/intechopen.109375
Salini, V., Saggini, A., Maccauro, G., Caraffa, A., Shaik-Dasthagirisaheb, Y.B. and Conti, P. (2011) Inflammatory Markers: Serum Amyloid A, Fibrinogen and C-Reactive Protein—A Revisited Study. European Journal of Inflammation, 9, 95-102. https://doi.org/10.1177/1721727X1100900202
Patrick, L. and Uzick, M. (2001) Cardiovascular Disease: C-Reactive Protein and the Inflammatory Disease Paradigm: HMG-CoA Reductase Inhibitors, Alpha-Tocopherol, Red Yeast Rice, and Olive Oil Polyphenols. A Review of the Literature. Alternative Medicine Review, 6, 248-271.
Li, J.J. and Fang, C.H. (2004) C-Reactive Protein Is Not Only an Inflammatory Marker But Also a Direct Cause of Cardiovascular Diseases. Medical Hypotheses, 62, 499-506. https://doi.org/10.1016/j.mehy.2003.12.014
King, D.E., Mainous, A.G., Buchanan, T.A. and Pearson, W.S. (2003) C-Reactive Protein and Glycemic Control in Adults with Diabetes. Diabetes Care, 26, 1535-1539. https://doi.org/10.2337/diacare.26.5.1535
Mirza, M.S. (2011) Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. International Scholarly Research Notices, 2011, Article ID: 592404. https://doi.org/10.5402/2011/592404
Kerner, A., Avizohar, O., Sella, R., Bartha, P., Zinder, O., Markiewicz, W., Levy, Y., Brook, G.J. and Aronson, D. (2005) Association between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 193-197. https://doi.org/10.1161/01.ATV.0000148324.63685.6a
Knight, M.L. (2015) The Application of High-Sensitivity C-Reactive Protein in Clinical Practice A 2015 Update. Us Pharmacist, 40, 50-53.
Chevance, A., Gourion, D., Hoertel, N., Llorca, P.M., Thomas, P., Bocher, R., Moro, M.R., et al. (2020) Ensuring Mental Health Care during the SARS-CoV-2 Epidemic in France: A Narrative Review. L’Encéphale, 46, 193-201. https://doi.org/10.1016/j.encep.2020.04.005
Krishnamurthy, H.K., Reddy, S., Jayaraman, V., Krishna, K., Song, Q., Rajasekaran, K.E., Wang, T.H., Bei, K. and Rajasekaran, J.J. (2021) Effect of Micronutrients on Thyroid Parameters. Journal of Thyroid Research, 2021, Article ID: 1865483. https://doi.org/10.1155/2021/1865483
Ridker, P.M. (2003) Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention. Circulation, 107, 363-369. https://doi.org/10.1161/01.CIR.0000053730.47739.3C
Cleeman, J.I., Grundy, S.M., Becker, D. and Clark, L. (2001) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III). Journal of the American Medical Association, 285, 2486-2497. https://doi.org/10.1001/jama.285.19.2486
Pearson, T.A., Mensah, G.A., Wayne Alexander, R., Anderson, J.L., Cannon III, R.O., Criqui, M., Fadl, Y.Y., et al. (2003) Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499-511. https://doi.org/10.1161/01.CIR.0000052939.59093.45
Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E. and Ridker, P.M. (2011) C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus. Journal of the American Medical Association, 286, 327-334. https://doi.org/10.1001/jama.286.3.327
Barzilay, J.I., Abraham, L., Heckbert, S.R., Cushman, M., Kuller, L.H., Resnick, H.E. and Tracy, R.P. (2001) The Relation of Markers of Inflammation to the Development of Glucose Disorders in the Elderly: The Cardiovascular Health Study. Diabetes, 50, 2384-2389. https://doi.org/10.2337/diabetes.50.10.2384
Ridker, P.M., Glynn, R.J. and Hennekens, C.H. (1998) C-Reactive Protein Adds to the Predictive Value of Total and HDL Cholesterol in Determining Risk of First Myocardial Infarction. Circulation, 97, 2007-2011. https://doi.org/10.1161/01.CIR.97.20.2007
Miki, K., Kitamura, M., Hatta, K., Kamide, K., Gondo, Y., Yamashita, M., Takedachi, M., et al. (2021) Periodontal Inflamed Surface Area Is Associated with hs-CRP in Septuagenarian Japanese Adults in Cross-Sectional Findings from the SONIC Study. Scientific Reports, 11, Article No. 14436. https://doi.org/10.1038/s41598-021-93872-8
Adela, R. and Banerjee, S.K. (2015) GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective. Journal of Diabetes Research, 2015, Article ID: 490842. https://doi.org/10.1155/2015/490842
Dallmeier, D., Larson, M.G., Vasan, R.S., Keaney, J.F., Fontes, J.D., Meigs, J.B., Fox, C.S. and Benjamin, E.J. (2012) Metabolic Syndrome and Inflammatory Biomarkers: A Community-Based Cross-Sectional Study at the Framingham Heart Study. Diabetology & Metabolic Syndrome, 4, Article No. 28. https://doi.org/10.1186/1758-5996-4-28
Isomaa, B.O., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.R. and Groop, L. (2001) Cardiovascular Morbidity and Mortality Associated with the Metabolic Syndrome. Diabetes Care, 24, 683-689. https://doi.org/10.2337/diacare.24.4.683
Yeniova, A.O., Küçükazman, M., Ata, N., Dal, K., Kefeli, A., Başyiğit, S., Aktaş, B., et al. (2014) High-Sensitivity C-Reactive Protein Is a Strong Predictor of Non-Alcoholic Fatty Liver Disease. Hepato-Gastroenterology, 61, 422-425.
Perera, S., Lohsoonthorn, V., Jiamjarasrangsi, W., Lertmaharit, S. and Williams, M.A. (2008) Association between Elevated Liver Enzymes and Metabolic Syndrome among Thai Adults. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2, 171-178. https://doi.org/10.1016/j.dsx.2008.04.012